CK1002閲嶇粍浜虹櫧浠嬬礌15(Recombinant Human IL15)
鍖呰涓庝环鏍硷細
浜у搧浠嬬粛
鐧戒粙绱?5锛圛L-15锛夋槸涓€绉嶅湪缁撴瀯鍜屽姛鑳戒笂涓嶪L-2鐩镐技鐨勭粏鑳炲洜瀛?瀹冭兘澶熷埡婵€T娣嬪反缁嗚優銆丅缁嗚優鍜孨K缁嗚優鐨勬椿鍖栧拰澧炴畺銆傚湪淇冪値鐥囥€佹姉鑲跨槫銆佹姉鎰熸煋涓捣閲嶈鐨勪綔鐢ㄣ€侷L-15 鑳藉璇卞 CTL 缁嗚優鍜 LAK 缁嗚優娲绘€ц€屼綋鐜版姉鑲跨槫娲绘€с€侟/p> 鏈骇鍝佺敤閲嶇粍澶ц偁鏉嗚弻鍩哄洜琛ㄨ揪鐢熶骇IL-15锛岄珮绾害锛屾棤鍔ㄧ墿婧愭€ф薄鏌撱€侟/p> 鏈骇鍝佷粎闄愮鐮斾娇鐢ㄣ€侟/p>
鍙傝€冩枃鐚?/strong> 1. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood. 2001 Jan 1;97(1):14-32. 2. Ma S, Caligiuri MA, Yu J. Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy. Trends Immunol. 2022 Oct;43(10):833-847. |
鍖椾含鐭ョ鏂板垱鐢熺墿鎶€鏈湁闄愬叕鍙伏/span>
鐢佃瘽:鐐瑰嚮&鏌ョ湅 鑱旂郴浜国 鏉ㄥコ澹?/span> 閭紪: 102299 鍦板潃: 鍖椾含甯傛槍骞冲尯涓浜戣胺鍥?3鍙锋ゼ6灞侟/span>
鍚屽搧鐗屼骇鍝侊細
鐩稿叧浜у搧锛欬/div>
|